{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T19:31:43Z","timestamp":1794598303773,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Collaborative Innovation Center for Translational Medicine at Shanghai Jiao Tong University School of Medicine","award":["TM201820"],"award-info":[{"award-number":["TM201820"]}]},{"name":"Collaborative Innovation Center for Translational Medicine at Shanghai Jiao Tong University School of Medicine","award":["TM201927"],"award-info":[{"award-number":["TM201927"]}]},{"name":"Clinical Science and Technology Innovation (clinical research and cultivation) project","award":["SHDC12019X35"],"award-info":[{"award-number":["SHDC12019X35"]}]},{"name":"Interdisciplinary Program of Shanghai Jiao Tong University","award":["ZH2018QNA27"],"award-info":[{"award-number":["ZH2018QNA27"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Cases of refractory\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia have been increasing recently; however, whether viral coinfection or macrolide-resistant\n                      <jats:italic>M.<\/jats:italic>\n                      infection contribute to the development of refractory\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      pneumonia remains unclear. This study aimed to investigate the impacts of viral coinfection and macrolide-resistant\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      infection on\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      pneumonia in hospitalized children and build a model to predict a severe disease course.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Nasopharyngeal swabs or sputum specimens were collected from patients with community-acquired pneumonia meeting our protocol who were admitted to Shanghai Children\u2019s Medical Center from December 1, 2016, to May 31, 2019. The specimens were tested with the FilmArray Respiratory Panel, a multiplex polymerase chain reaction assay that detects 16 viruses,\n                      <jats:italic>Bordetella pertussis<\/jats:italic>\n                      ,\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      , and\n                      <jats:italic>Chlamydophila pneumoniae<\/jats:italic>\n                      . Univariate and multivariate logistic regression models were used to identify the risk factors for adenovirus coinfection and macrolide-resistant mycoplasma infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 107\u2009\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      pneumonia patients, the coinfection rate was 56.07%, and 60 (60\/107, 56.07%) patients were infected by drug-resistant\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      . Adenovirus was the most prevalent coinfecting organism, accounting for 22.43% (24\/107). The classification tree confirmed that viral coinfection was more common in patients younger than 3\u2009years old. Adenovirus coinfection and drug-resistant\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      infection occurred more commonly in patients with refractory\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      pneumonia (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.019;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001). A prediction model including wheezing, lung consolidation and extrapulmonary complications was used to predict adenovirus coinfection. The area under the receiver operating characteristic curve of the prediction model was 0.795 (95% CI 0.679\u20130.893,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). A prolonged fever duration after the application of macrolides for 48\u2009h was found more commonly in patients infected by drug-resistant\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002). A fever duration longer than 7\u2009days was an independent risk factor for drug-resistant\n                      <jats:italic>Mycoplasma<\/jats:italic>\n                      infection (OR\u2009=\u20093.500, 95% CI\u2009=\u20091.310\u20139.353,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.012).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The occurrence of refractory\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      pneumonia is associated with adenovirus coinfection and infection by drug-resistant\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      . A prediction model combining wheezing, extrapulmonary complications and lung consolidation can be used to predict adenovirus coinfection in children with\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      pneumonia. A prolonged fever duration indicates drug-resistant\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      infection, and a reasonable change in antibiotics is necessary.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05356-1","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:12:03Z","timestamp":1598400723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia"],"prefix":"10.1186","volume":"20","author":[{"given":"Yajuan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruike","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7637-2068","authenticated-orcid":false,"given":"Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"issue":"5","key":"5356_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/BF01726370","volume":"16","author":"D Gendrel","year":"1997","unstructured":"Gendrel D, Raymond J, Moulin F, et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis. 1997;16(5):388\u201391.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"5356_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.rmr.2012.06.012","volume":"30","author":"B Sztrymf","year":"2013","unstructured":"Sztrymf B, Jacobs F, Fichet J, et al. Mycoplasma-related pneumonia: a rare cause of acute respiratory distress syndrome (ARDS) and of potential antibiotic resistance[J]. Rev Mal Respir. 2013;30(1):77\u201380.","journal-title":"Rev Mal Respir"},{"issue":"3","key":"5356_CR3","first-page":"223","volume":"57","author":"A Tamura","year":"2008","unstructured":"Tamura A, Matsubara K, Tanaka T, et al. Methylprednisolone pulse therapy for refractory mycoplasma pneumoniae pneumonia in children[J]. J Inf Secur. 2008;57(3):223\u20138.","journal-title":"J Inf Secur"},{"key":"5356_CR4","first-page":"800","volume":"7","author":"I Koichi","year":"2016","unstructured":"Koichi I. Clinical features of severe or fatal mycoplasma pneumoniae pneumonia[J]. Front Microbiol. 2016;7:800.","journal-title":"Front Microbiol"},{"issue":"5","key":"5356_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.7883\/yoken.JJID.2016.355","volume":"70","author":"JL Yu","year":"2017","unstructured":"Yu JL, Song QF, Xie ZW, Jiang WH, Chen JH, Fan HF, et al. An iTRAQ-based quantitative proteomics study of refractory mycoplasma pneumoniae pneumonia patients. Jpn J Infect Dis. 2017;70(5):571\u20138.","journal-title":"Jpn J Infect Dis"},{"issue":"6","key":"5356_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2217\/17460913.3.6.635","volume":"3","author":"KB Waites","year":"2008","unstructured":"Waites KB, Balish MF, Atkinson TP. New insights into the pathogenesis and detection of mycoplasma pneumoniae infections. Future Microbiol. 2008;3(6):635\u201348.","journal-title":"Future Microbiol"},{"issue":"11","key":"5356_CR7","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1017\/S0950268818000778","volume":"146","author":"ZC XinxingZhang","year":"2018","unstructured":"XinxingZhang ZC. WenjingGu, et al. viral and bacterial co-infection in hospitalised children with refractory mycoplasma pneumoniae pneumonia[J]. Epidemiol Infect. 2018;146(11):1384\u20138.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"5356_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","volume":"16","author":"M Morozumi","year":"2010","unstructured":"Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010;16(2):78\u201386.","journal-title":"J Infect Chemother"},{"issue":"Suppl 2","key":"5356_CR9","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2011-200598","volume":"66","author":"M Harris","year":"2011","unstructured":"Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66(Suppl 2):ii1\u201323.","journal-title":"Thorax"},{"key":"5356_CR10","first-page":"745","volume":"51","author":"Pediatrics of Chinese medical association branch of breathing group","year":"2013","unstructured":"Pediatrics of Chinese medical association branch of breathing group. The Chinese journal pediatrics editorial board. The management of community acquired pneumonia in infants and children clinical practice guidelines. Chin J Pediatr. 2013;51:745\u201352.","journal-title":"Chin J Pediatr"},{"issue":"10","key":"5356_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026047","volume":"6","author":"MA Poritz","year":"2011","unstructured":"Poritz MA, Blaschke AJ, Byington CL, et al. FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection[J]. PLoS One. 2011;6(10):e26047.","journal-title":"PLoS One"},{"key":"5356_CR12","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12879-018-3429-6","volume":"18","author":"J Li","year":"2018","unstructured":"Li J, Tao Y, Tang M, et al. Rapid detection of respiratory organisms with the FilmArray respiratory panel in a large children's hospital in China. BMC Infect Dis. 2018;18:510.","journal-title":"BMC Infect Dis"},{"key":"5356_CR13","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1128\/JCM.05010-11","volume":"49","author":"MJ Loeffelholz","year":"2011","unstructured":"Loeffelholz MJ, Pong DL, Pyles RB, et al. Comparison of the FilmArray respiratory panel and Prodesse real-time PCR assays for detection of respiratory pathogens[J]. J Clin Microbiol. 2011;49:4083\u20138.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"5356_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1542\/peds.113.4.701","volume":"113","author":"IC Michelow","year":"2004","unstructured":"Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children[J]. Pediatrics. 2004;113(4):701\u20137.","journal-title":"Pediatrics"},{"key":"5356_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13052-014-0104-4","volume":"40","author":"M Biljana","year":"2014","unstructured":"Biljana M, Marina AM, Snezana R, et al. Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis[J]. Ital J Pediatr. 2014;40:104.","journal-title":"Ital J Pediatr"},{"key":"5356_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00006454-200004000-00006","volume":"19","author":"T Juve\u2019n","year":"2000","unstructured":"Juve\u2019n T. Etiology of community-acquired pneumonia in 254 hospitalized children[J]. Pediatr Infect Dis J. 2000;19:293\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"5356_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jmii.2013.06.006","volume":"48","author":"CY Chiu","year":"2015","unstructured":"Chiu CY, Chen CJ, Wong KS, et al. Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia[J]. J Microbiol Immunol Infect. 2015;48(1):51\u20136.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"5356_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1186\/s12879-019-4426-0","volume":"19","author":"M-c Zhao","year":"2019","unstructured":"Zhao M-c, Wang L, Qiu F-z, et al. Impact and clinical profiles of mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia[J]. BMC Infect Dis. 2019;19(1):835.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"5356_CR19","first-page":"15666","volume":"8","author":"Q Song","year":"2015","unstructured":"Song Q, Xu BP, Shen KL. Effects of bacterial and viral co-infections of mycoplasma pneumoniae pneumonia in children: analysis report from Beijing Children\u2019s hospital between 2010 and 2014 [J]. Int J Clin Exp Med. 2015;8(9):15666\u201374.","journal-title":"Int J Clin Exp Med"},{"issue":"8","key":"5356_CR20","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3201\/eid2108.150273","volume":"21","author":"X Zheng","year":"2015","unstructured":"Zheng X, Lee S, Selvarangan R, et al. Macrolide-resistant mycoplasma pneumoniae, United States. [J]. Emerg Infect Dis. 2015;21(8):1470\u20132.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"5356_CR21","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/s12879-019-4228-4","volume":"19","author":"D Guo","year":"2019","unstructured":"Guo D, Hu W, Xu B, et al. Allele-specific real-time PCR testing for minor macrolide-resistant mycoplasma Pneumoniae[J]. BMC Infect Dis. 2019;19(1):616.","journal-title":"BMC Infect Dis"},{"key":"5356_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijid.2019.03.028","volume":"83","author":"J Qu","year":"2019","unstructured":"Qu J, Chen S, Bao F, et al. Molecular characterization and analysis of mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China[J]. Int J Infect Dis. 2019;83:26\u201331.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"5356_CR23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/ppul.22706","volume":"48","author":"PS Wu","year":"2013","unstructured":"Wu PS, Chang LY, Lin HC, et al. Epidemiology and clinical manifestations of children with macrolide-resistant mycoplasma pneumoniae pneumonia in Taiwan. [J]. Pediatr Pulmonol. 2013;48(9):904\u201311.","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"5356_CR24","first-page":"288","volume":"19","author":"DX Guo","year":"2019","unstructured":"Guo DX, Hu WJ, Wei R, et al. Epidemiology and mechanism of drug resistance of Mycoplasma pneumoniae in Beijing, China: A multicenter study[J]. Bosn J Basic Med Sci. 2019;19(3):288\u201396.","journal-title":"Bosn J Basic Med Sci"},{"key":"5356_CR25","first-page":"57(11)","volume":"23","author":"KB Waites","year":"2019","unstructured":"Waites KB, Ratliff A, Crabb DM, et al. Macrolide-resistant mycoplasma pneumoniae in the United States as determined from a National Surveillance Program[J]. J Clin Microbiol. 2019;23:57(11).","journal-title":"J Clin Microbiol"},{"issue":"Pt 12","key":"5356_CR26","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1099\/jmm.0.066191-0","volume":"62","author":"GD Ferguson","year":"2013","unstructured":"Ferguson GD, Gadsby NJ, Henderson SS, et al. Clinical outcomes and macrolide resistance in mycoplasma pneumoniae infection in Scotland, UK[J]. J Med Microbiol. 2013;62(Pt 12):1876\u201382.","journal-title":"J Med Microbiol"},{"issue":"10","key":"5356_CR27","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3201\/eid2310.170106","volume":"23","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Oishi T, Miyata I, et al. Macrolide-resistant mycoplasma pneumoniae infection, Japan, 2008\u20132015. Emerg Infect Dis. 2017;23(10):1703\u20136.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"5356_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1442-200X.2010.03316.x","volume":"53","author":"S Uehara","year":"2011","unstructured":"Uehara S, Sunakawa K, Eguchi H, et al. Japanese guidelines for the management of respiratory infectious diseases in children 2007 with focus on pneumonia. Pediatr Int. 2011;53(2):264\u201376.","journal-title":"Pediatr Int"},{"issue":"5","key":"5356_CR29","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1128\/AAC.00048-13","volume":"57","author":"Y Kawai","year":"2013","unstructured":"Kawai Y, Miyashita N, Kubo M, et al. Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant mycoplasma pneumoniae pneumonia in pediatric patients. Antimicrob Agents Chemother. 2013;57(5):2252\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5356_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1440-1843.2011.02102.x","volume":"17","author":"Y Kawai","year":"2012","unstructured":"Kawai Y, Miyashita N, Yamaguchi T, et al. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant mycoplasma pneumoniae pneumonia in paediatric patients. Respirology. 2012;17(2):354\u201362.","journal-title":"Respirology."},{"issue":"3","key":"5356_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173635","volume":"12","author":"N Ishiguro","year":"2017","unstructured":"Ishiguro N, Koseki N, Kaiho M, et al. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive mycoplasma pneumoniae pneumonia in pediatric patients. PLoS One. 2017;12(3):e0173635.","journal-title":"PLoS One"},{"issue":"4","key":"5356_CR32","doi-asserted-by":"publisher","first-page":"ofv178","DOI":"10.1093\/ofid\/ofv178","volume":"2","author":"NW Carris","year":"2015","unstructured":"Carris NW, Pardo J, Montero J, et al. Minocycline as A substitute for doxycycline in targeted scenarios: a systematic review. Open Forum Infect Dis. 2015;2(4):ofv178.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"5356_CR33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1542\/peds.86.1.123","volume":"86","author":"JS Abramson","year":"1990","unstructured":"Abramson JS, Givner LB. Should tetracycline be contraindicated for therapy of presumed Rocky Mountain spotted fever in children less than 9 years of age? Pediatrics. 1990;86(1):123\u20134.","journal-title":"Pediatrics."},{"issue":"12","key":"5356_CR34","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/cid\/cis784","volume":"55","author":"O Takafumi","year":"2012","unstructured":"Takafumi O, Miyuki M, Takeshi T, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children[J]. C Clin Infect Dis. 2012;55(12):1642\u20139.","journal-title":"C Clin Infect Dis"},{"issue":"5","key":"5356_CR35","doi-asserted-by":"publisher","first-page":"632","DOI":"10.21037\/apm.2019.10.05","volume":"8","author":"M Lin","year":"2019","unstructured":"Lin M, Shi L, Huang A, et al. Efficacy of levofloxacin on macrolide-unresponsive and corticosteroid-resistant refractory mycoplasma pneumoniae pneumonia in children[J]. Ann Palliat Med. 2019;8(5):632\u20139.","journal-title":"Ann Palliat Med"},{"issue":"12","key":"5356_CR36","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/cid\/cis784","volume":"55","author":"T Okada","year":"2012","unstructured":"Okada T, Morozumi M, Tajima T, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55(12):1642\u20139.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05356-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T19:01:26Z","timestamp":1668020486000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05356-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5356"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05356-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-29508\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29508\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29508\/v2","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board and the Ethics Committee of Shanghai Children\u2019s Medical Center (SCMCIRB-K2017044), and written informed consent was obtained from the parents of each patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"633"}}